CEO Debra Crew has stepped down after two years in the job, the world's biggest spirits maker has said, with finance chief Nik Jhangiani taking over in the interim as the company strives to boost its ...

Reckitt Benckiser is selling a majority stake in its home-care business, home to Air Wick fresheners and Cillit Bang cleaning products, to Advent International in a deal that values the whole unit at ...

Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...

Kenvue, makers of Benadryl, introduces 'Cough Clinics' in partnership with the Association of Physicians of India. This ...

Inventiva named Jason Campagna as president of R&D and chief medical officer, and Martine Zimmermann as EVP of regulatory affairs and quality assurance. Evolent named Dr. David Lim as chief clinical ...

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

Kenvue Inc. closed 13.19% below its 52-week high of $25.17, which the company achieved on May 8th.

Experts are raising concerns about Benadryl’s ability to cross the blood-brain barrier and potential lasting impacts.

Kenvue Inc. has announced a leadership change and the initiation of a strategic review aimed at optimizing its brand portfolio and operating model. Kirk Perry, a Kenvue board member and former ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...

The stock's fall snapped a four-day winning streak.

We recently published 10 Stocks Jim Cramer Discussed As He Commented On Latest Tariffs. Kenvue Inc. (NYSE:KVUE) is one of the ...